Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results

Annual consolidated operating cash flow fell to $49.6 million from $118.4 million, largely reflecting Feminine Care divestiture-related impacts.

Rhea-AI Summary

Edgewell Personal Care (EPC) reported fourth-quarter fiscal 2026 net sales of $484.1 million, up from the prior-year quarter. Sales rose 3.0%, or 3.1% excluding currency movements. Earnings per diluted share from continuing operations fell to $0.23 from $0.26, while adjusted earnings per share rose to $0.78 from $0.52.

For the year ended September 30, 2026, sales increased 1.8% to $1,996.5 million. The continuing-operations loss was $2.2 million, versus earnings of $44.3 million; adjusted earnings per share increased to $1.93 from $1.81. Restructuring costs totaled $101.8 million. Year-end cash was $375.6 million, with $418.8 million available under its U.S. revolving credit facility.

For fiscal 2027, Edgewell expects organic sales growth of approximately 1.0%–3.0%, GAAP earnings per share of $0.90–$1.20 and adjusted earnings per share of $1.85–$2.15. Results exclude Feminine Care, treated as discontinued operations.

26 points · 0 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 24 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate pointFourth-quarter sales increased 3.0% to $484.1 million; organic sales rose 3.1% year over year.
• Moderate pointFourth-quarter adjusted earnings per share rose 50.0% to $0.78 from $0.52.
• Moderate pointFourth-quarter gross margin increased 320 basis points to 43.3%; gross profit reached $209.6 million versus $188.4 million.
• Moderate pointFourth-quarter adjusted gross margin increased 510 basis points to 45.7%.
• Moderate pointFourth-quarter operating income rose to $16.9 million from $6.9 million; margin increased to 3.5% from 1.5%.
• Moderate pointFourth-quarter adjusted operating income rose to $51.1 million from $27.7 million; margin reached 10.6% versus 5.9%.
• Moderate pointFourth-quarter adjusted EBITDA, an adjusted earnings measure, increased to $76.8 million from $43.0 million.
• Moderate pointFiscal 2026 sales increased 1.8% to $1,996.5 million; organic sales increased 0.3%.
• Moderate pointFiscal 2026 adjusted earnings per share rose 6.6% to $1.93 from $1.81.
• Moderate pointFiscal 2026 adjusted EBITDA increased to $254.5 million from $239.7 million.
• Moderate point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 reported sales are expected to grow approximately 0.4%–2.4%; organic growth is expected at approximately 1.0%–3.0%.
• Moderate point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 GAAP earnings per share are expected at $0.90–$1.20, versus fiscal 2026's $0.05 loss.
• Moderate point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 adjusted earnings per share are expected at $1.85–$2.15, versus $1.93 in fiscal 2026.
• Moderate point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 adjusted EBITDA is expected at $250–$270 million, versus $254.5 million in fiscal 2026.
• Moderate point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 adjusted free cash flow is expected at approximately $100–$120 million.

11 minor points

• Minor pointFourth-quarter adjusted SG&A expense fell to 20.6% of sales from 21.9%.
• Minor pointFourth-quarter North America organic sales increased 3.3%; International organic sales increased 3.0%.
• Minor pointWet Shave quarterly sales increased 1.2%; organic sales grew 1.6%, despite lower Private Label sales.
• Minor pointWet Shave quarterly segment profit increased 10.8%; excluding favorable currency effects, profit increased 4.8%.
• Minor pointSun and Skin Care quarterly sales increased 7.0%; organic sales rose 6.5%, driven by global Grooming.
• Minor pointSun and Skin Care quarterly segment profit increased 294.0%; organic segment profit increased 278.0%.
• Minor pointFiscal 2026 North America organic sales increased 0.4%; International organic sales increased 0.2%.
• Minor pointOther net income reached $26.7 million annually versus $0.2 million; quarterly income replaced a $2.1 million expense.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 adjusted operating margin is expected to increase approximately 70 basis points.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 adjusted gross margin is expected to expand approximately 60 basis points.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 lower SG&A is expected to contribute approximately 90 basis points to adjusted operating margin improvement.

Negative

• Moderate pointFiscal 2026 continuing operations posted a $2.2 million loss, versus $44.3 million earnings; diluted EPS fell to $(0.05) from $0.93.
• Moderate pointAnnual consolidated operating cash flow fell to $49.6 million from $118.4 million, largely reflecting divestiture-related impacts.
• Moderate pointFiscal 2026 operating income fell to $41.4 million from $110.2 million; margin declined to 2.1% from 5.6%.
• Moderate pointFiscal 2026 adjusted operating income fell to $161.6 million from $173.3 million; margin declined to 8.1% from 8.8%.
• Moderate pointFiscal 2026 restructuring costs totaled $101.8 million; fourth-quarter costs were $29.9 million. 7.6% of market cap
• Moderate point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 restructuring and repositioning actions are expected to incur approximately $55 million in pre-tax charges. 4.1% of market cap
• Moderate pointFiscal 2026 gross profit fell to $830.0 million from $847.8 million; gross margin declined 160 basis points to 41.6%.
• Moderate pointFourth-quarter continuing-operations earnings fell to $10.7 million from $12.1 million; diluted EPS declined to $0.23 from $0.26.
• Moderate pointFiscal 2026 adjusted effective tax rate increased to 23.0% from 11.0%.

15 minor points

• Minor pointFiscal 2026 adjusted gross margin declined 10 basis points to 43.4%, with inflation and unfavorable mix outweighing benefits.
• Minor pointFiscal 2026 advertising and promotion expense rose $15.6 million to $243.5 million; quarterly expense rose $10.2 million.
• Minor pointFiscal 2026 SG&A expense increased to $428.9 million from $408.6 million; quarterly expense increased to $107.2 million from $105.5 million.
• Minor pointFiscal 2026 adjusted SG&A increased to 20.5% of sales from 20.4%, reflecting higher corporate and consulting costs.
• Minor pointFourth-quarter debt interest expense increased to $15.0 million from $14.8 million.
• Minor pointWet Shave Private Label sales declined amid temporary supply constraints in North America and certain international markets.
• Minor pointNorth America Sun Care and Skin Care sales declined in the fourth quarter, partially offsetting global Grooming growth.
• Minor pointFiscal 2026 North America Wet Shave and Skin Care declines partially offset Grooming and Sun Care volume gains.
• Minor pointFiscal 2026 International organic growth reflected pricing, partially offset by lower volumes.
• Minor pointYear-end adjusted net debt leverage stood at 3.4x.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 sales guidance includes an estimated 60-basis-point negative currency impact.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 higher advertising investment is expected to reduce adjusted operating margin by approximately 80 basis points.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 debt interest expense is expected at approximately $67 million.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 adjusted effective tax rate is expected at approximately 24%, versus 23.0% in fiscal 2026.
• Minor point. Forward-looking: it has not happened yet and may not happen.Fiscal 2027 capital expenditures are expected at approximately 2.75%–3.25% of net sales.

News Explained

Fiscal 2027 actions are expected to add about $55 million in pretax restructuring and repositioning charges.

The board declared a $0.15-per-common-share cash dividend, payable January 7, 2027 to shareholders of record December 3, 2026, setting a scheduled cash payment for eligible holders.

For fiscal 2027, the company expects about $55 million in pretax charges from restructuring and repositioning actions, including further Wet Shave consolidation and global transformation actions.

Key Figures

Fourth-quarter net sales: $484.1 million; +3.0% Fourth-quarter adjusted EPS: $0.78; +50.0% Fiscal-year net sales: $1,996.5 million; +1.8% +5 more

Fourth-quarter net sales

$484.1 million; +3.0%

Fiscal 2026 fourth quarter

Fourth-quarter adjusted EPS

$0.78; +50.0%

Fiscal 2026 fourth quarter

Fiscal-year net sales

$1,996.5 million; +1.8%

Fiscal 2026

Fiscal-year organic net sales

+0.3%

Fiscal 2026

Fiscal-year GAAP EPS

$(0.05)

Fiscal 2026

Fiscal-year adjusted EPS

$1.93; +6.6%

Fiscal 2026

Adjusted EPS outlook

$1.85–$2.15

Fiscal 2027

Adjusted EBITDA outlook

$250–$270 million

Fiscal 2027

Historical Context

1 past event · Latest: Aug 05

1 event

1. Aug 05

   Q3 earnings

   24h Move

   +2.4%

   Q3 results tightened FY2026 outlook; this report provides full-year outcomes against that outlook.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

gaap, revolving credit facility, transition services agreement, discontinued operations

4 terms

gaap financial

"GAAP Diluted Net Earnings (Loss) from Continuing Operations Per Share"

GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.

View in glossary

revolving credit facility financial

"access to an additional $418.8 million under the Company's U.S. revolving credit facility"

A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.

transition services agreement financial

"Transition Services Agreement ("TSA") income"

A transition services agreement is a formal arrangement where one company continues to provide essential services—such as IT, human resources, or accounting—to another company after a business deal or change in ownership. It acts like a temporary bridge, ensuring smooth operations during a transition period. For investors, it provides clarity on how long support will last and helps assess potential costs and stability during the change.

discontinued operations financial

"the Feminine Care business which is treated as discontinued operations"

Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Fourth Quarter Net Sales Increased 3.0%, or 3.1% Organic; GAAP EPS $0.23, Adjusted EPS $0.78, or +50.0%

Fiscal 2026 Net Sales Increased 1.8%, or 0.3% Organic; GAAP EPS $(0.05), Adjusted EPS $1.93, or +6.6%

Provides Fiscal 2027 Outlook; Expects Growth in Organic Net Sales, Adjusted EBITDA and Adjusted EPS

SHELTON, Conn., Nov. 12, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) today announced results for its fourth fiscal quarter 2026 and fiscal year ended September 30, 2026. 

Executive Summary

• Fourth quarter net sales were $484.1 million, an increase of 3.0% compared to the prior year quarter. Full year net sales were $1,996.5 million, an increase of 1.8% compared to the prior year.
• Organic net sales increased 3.1% for the quarter and increased 0.3% for the full year. (Organic basis excludes the impact from currency movements).
• GAAP Diluted Net Earnings (Loss) from Continuing Operations Per Share ("EPS") were $0.23, compared to $0.26 in the prior year quarter and $(0.05) for the full fiscal year compared to $0.93 for the prior year.
• Adjusted EPS were $0.78 for the quarter, compared to $0.52 in the prior year quarter and $1.93 for the full fiscal year compared to $1.81 for the prior year.
• Ended the fourth quarter with $375.6 million in cash on hand, plus access to an additional $418.8 million under the Company's U.S. revolving credit facility.
• Returned $6.9 million to shareholders in the form of dividends in the fourth quarter.
• The Board of Directors declared a cash dividend of $0.15 per common share on November 12, 2026, for the fourth quarter.

"Fiscal 2026 was a year of meaningful progress and change for Edgewell, culminating in a strong fourth quarter that reflected continued growth in North America, a return to growth in International and stronger performance across our focus brands," said Rod Little, President and Chief Executive Officer. "Our second-half performance enabled us to deliver the top- and bottom-line outlook we established at the beginning of the year on an adjusted basis, providing further evidence that our investments in innovation, brand building and commercial execution are gaining traction. We enter fiscal 2027 as a more focused business, with confidence in our plans to build on this progress, increase support behind our brands and improve profitability. While significant cost and competitive headwinds persist, we believe the broader transformation of our operating model is creating greater capacity to invest and supporting more consistent growth and margin expansion."

Unless otherwise noted, reported results in this release are based on continuing operations and exclude the Feminine Care business which is treated as discontinued operations. The Company reports and forecasts results on a GAAP and non-GAAP basis and has reconciled non-GAAP results and outlook to the most directly comparable GAAP measures later in this release. See non-GAAP Financial Measures for a more detailed explanation, including definitions of various non-GAAP terms used in this release. All comparisons used in this release are for the same period in the prior fiscal year unless otherwise stated.

Fiscal 4Q 2026 Operating Results (Unaudited)

Net sales were $484.1 million in the quarter, an increase of $14.2 million, or 3.0%, including a $0.5 million, or 0.1% unfavorable impact from currency movements. Organic net sales increased $14.7 million, or 3.1%, reflecting broad-based growth across the business, including growth in both North America and International. North America organic sales increased 3.3%, driven by growth in Grooming and Wet Shave, reflecting improved execution, increased distribution and continued strength across several of the Company's focus brands. International organic sales increased 3.0%, reflecting growth across all segments.

Gross profit was $209.6 million, as compared to $188.4 million in the prior year quarter. Gross margin as a percent of net sales was 43.3%, an increase of 320-basis points. Adjusted gross margin increased 510-basis points, to 45.7%, driven by productivity savings, favorable volume absorption, favorable currency, and the lapping of transitory costs in the prior year period, partially offset by higher inflation, net of tariffs, and unfavorable mix.

Advertising and sales promotion expense ("A&P") was $56.1 million, or 11.6% of net sales, an increase of $10.2 million, compared to $45.9 million, or 9.8% of net sales in the prior year quarter. The increase reflects continued investment behind the Company's focus brands and growth priorities, including expanded media support and brand-building initiatives.     

Selling, general and administrative expense ("SG&A") was $107.2 million, or 22.1% of net sales, as compared to $105.5 million, or 22.5% of net sales in the prior year quarter. Adjusted SG&A was 20.6% of net sales, compared to 21.9% in the prior year quarter. The improvement primarily reflects lower corporate and people-related expenses.   

The Company recorded pre-tax restructuring and related costs in support of cost efficiency and effectiveness programs of $29.9 million in the quarter.

Operating income was $16.9 million, or 3.5% of net sales, inclusive of $4.0 million favorable impact from currency movements, compared to income of $6.9 million, or 1.5% of net sales in the prior year quarter. Adjusted operating income was $51.1 million, or 10.6% of net sales, compared to $27.7 million, or 5.9% of net sales in the prior year quarter.

Interest expense associated with debt was $15.0 million, compared to $14.8 million in the prior year quarter. The increase in interest expense was the result of lower capitalized interest for projects with capital expenditures, partially offset by lower borrowing levels on the Company's U.S. revolving credit facility due to the paydown of the facility with the proceeds of the Feminine Care divestiture.

Other (income) expense, net was income of $8.3 million compared to expense of $2.1 million in the prior year quarter. The current year quarter included $7.2 million of Transition Services Agreement ("TSA") income. Additionally, the prior year quarter included $0.8 million of other project gains. Currency hedge and remeasurement gains were $0.3 million in the current quarter, compared to a loss of $2.0 million in the prior year quarter. Adjusted other (income) expense, net was income of $8.7 million compared to expense of $2.9 million in the prior year quarter.

The effective tax rate for fiscal 2026 was (175.3)% compared to (19.1)% in the prior year period. The current year period reflects a tax expense on a loss while fiscal 2025 reflects a tax benefit on income. The fiscal 2026 effective tax rate reflects less favorable discrete and unusual items compared to fiscal 2025. The adjusted effective tax rate for fiscal 2026 was 23.0%, compared to 11.0% in the prior year period.

GAAP net earnings from continuing operations were $10.7 million of income, or $0.23 per diluted share, compared to income of $12.1 million, or $0.26 per diluted share, in the prior year quarter. Adjusted net earnings from continuing operations were $36.8 million, or $0.78 per share, inclusive of a $0.11 favorable currency impact, compared to $24.3 million, or $0.52 per share, in the prior year quarter. Adjusted EBITDA was $76.8 million, inclusive of a $6.3 million favorable currency impact, compared to $43.0 million in the prior year quarter. 

Net cash provided by operating activities on a consolidated basis, inclusive of continuing and discontinued operations was $49.6 million for the year ended September 30, 2026, compared to $118.4 million in the prior year period. The decrease in cash provided by operating activities was largely driven by one-time operating cash flow impacts associated directly with the Feminine Care divestiture including tax, working capital, and deal related fees and expenses. The fourth quarter ended with $375.6 million in cash on hand and access to $418.8 million under the Company's U.S. revolving credit facility. Adjusted net debt leverage ratio at the end of the fourth quarter was 3.4x.

Fiscal 4Q 2026 Operating Segment Results (Unaudited)

Wet Shave (Men's Systems, Women's Systems, Disposables, and Shave Preps)

Net sales increased $3.9 million, or 1.2%. Organic net sales increased $5.2 million or 1.6%, as growth in the branded business more than offset lower Private Label sales related to temporary supply constraints in North America and certain international markets. Segment profit increased $5.7 million, or 10.8%. Organic segment profit, excluding the favorable impact from currency, increased $2.5 million, or 4.8%, as the benefits of higher gross profit were partially offset by higher marketing and SG&A expenses.

Sun and Skin Care (Sun Care, Men's and Women's Grooming Products, and Wet Ones)

Net sales increased $10.3 million, or 7.0%. Organic net sales increased $9.5 million, or 6.5%, driven by strong global Grooming performance, partially offset by declines in North America Sun Care and Skin Care. Segment profit increased $14.7 million, or 294.0%, including a favorable impact from foreign currency of $0.8 million, or 16.0%. Organic segment profit increased $13.9 million, or 278.0%, as the benefits of higher gross profit and lower SG&A expense were partially offset by increased investment behind the Company's brands.

Fiscal 2026 Operating Results (Unaudited)

Net sales were $1,996.5 million, an increase of $34.5 million, or 1.8%. Organic net sales increased 0.3%. North America organic net sales increased 0.4%, primarily attributable to higher volumes in Grooming and Sun Care, partially offset by declines in Wet Shave and Skin Care. International organic net sales increased 0.2%, driven by pricing, partially offset by lower volumes.

Gross Profit was $830.0 million, compared to $847.8 million in the prior year. Gross margin as a percent of net sales was 41.6%, a decrease of 160-basis points compared to the prior year period. Adjusted gross margin decreased 10-basis points, to 43.4%,  as 230 basis points of productivity savings, favorable currency and slightly favorable net pricing, were more than offset by 250 basis points of core inflation, inclusive of tariffs, and 60 basis points of unfavorable mix and other. 

A&P was $243.5 million, or 12.2% of net sales, an increase of $15.6 million from the prior year, compared to 11.6% in the prior year, reflecting increased investment behind the Company's focus brands and growth priorities in North America and International markets.

Selling, general and administrative expense ("SG&A") was $428.9 million, or 21.5%, of net sales, as compared to $408.6 million, or 20.8%, of net sales in the prior year. Adjusted SG&A as a percent of net sales was 20.5% as compared to 20.4% in the prior year, due to higher corporate expenses and consulting costs.

The Company recorded pre-tax restructuring and related costs of $101.8 million, consisting largely of severance, project implementation and other exit costs in support of transformation and cost efficiency programs. These costs included $80.0 million related to the consolidation of its Mexico facilities and Wet Shave operations and $21.8 million related to global transformation actions to strengthen its operating model and support the Company's new growth strategy and commercial ambitions.

Operating income was $41.4 million, or 2.1% of net sales, inclusive of $11.7 million favorable impact from currency movements, compared to $110.2 million, or 5.6% of net sales, in the prior year. Adjusted operating income was $161.6 million, or 8.1% of net sales, compared to $173.3 million, or 8.8%, of net sales in the prior year. The decrease in adjusted operating income margin was attributable to higher brand investment, lower gross margin, and higher SG&A.

Other (income) expense, net was income of $26.7 million in fiscal 2026 compared to income of $0.2 million in the prior year period. The current year included $21.5 million of Transition Services Agreement ("TSA") income. The impact was partially offset by currency hedge and remeasurement losses of $0.8 million in fiscal 2026 compared to losses of $0.6 million in fiscal 2025. Adjusted other (income) expense, net was income of $24.9 million compared to expense of $3.0 million in the prior year period. The current year period included $0.7 million of other project gains, compared to $2.3 million of other project gain in fiscal 2025.

GAAP net (loss) earnings from continuing operations were $(2.2) million or $(0.05) per diluted share compared to $44.3 million or $0.93 per diluted share in the prior year period. Adjusted net earnings were $90.5 million or $1.93 per share, inclusive of a $0.20 favorable impact from currency movements, compared to $86.3 million or $1.81 per share in the prior year period. Adjusted EBITDA was $254.5 million, inclusive of an $11.5 million favorable currency impact, compared to $239.7 million in the prior year. 

Capital Allocation

On November 12, 2026, the Board of Directors declared a quarterly cash dividend of $0.15 per common share for the fourth fiscal quarter of fiscal 2026. The dividend will be payable on January 7, 2027 to shareholders of record at the close of business on December 3, 2026.  During the fourth quarter of fiscal 2026, the Company paid dividends totaling $6.9 million to stockholders. As of September 30, 2026, the Company had approximately $85 million available for share repurchase in the future under the Board's 2025 authorization.

Full Fiscal Year 2027 Financial Outlook

The Company is providing the following outlook assumptions for fiscal 2027.

• Reported net sales are expected to increase in the range of approximately 0.4% to 2.4%
  • Includes an estimated 60-basis point negative impact from foreign currency changes
• Organic net sales are expected to increase in the range of approximately 1.0% to 3.0%
• GAAP EPS is expected to be in the range of $0.90 to $1.20
  • Includes: Restructuring and related costs*, Sun Care reformulation, and Other costs
• Adjusted EPS is expected to be in the range of $1.85 to $2.15
• Adjusted operating margin is expected to increase approximately 70 basis points, including approximately 60 basis points of adjusted gross margin expansion and approximately 90 basis points of lower SG&A, partially offset by approximately 80 basis points of higher A&P investment.
• Adjusted EBITDA is expected to be in the range of $250 to $270 million
• Other income, net is expected to be approximately $13 million
• Interest expense associated with debt is expected to be approximately $67 million
• Adjusted effective tax rate is expected to be approximately 24%
• Capital expenditures are expected to be in the range of approximately 2.75% to 3.25% of net sales
• Adjusted free cash flow is expected to be approximately $100 to $120 million

*In fiscal 2027, the Company is taking specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency through restructuring and repositioning actions, including the further consolidation of Wet Shave operations. Additionally, the Company announced global transformation actions to deliver its new growth strategy and commercial ambitions. As a result of these actions, the Company expects to incur pre-tax charges of approximately $55 million for the full fiscal year.

Webcast Information

In conjunction with this announcement, the Company will hold an investor conference call beginning at 8:00 a.m. Eastern Time today, November 12, 2026. All interested parties may access a live webcast of this conference call at www.edgewell.com, under the "Investors," and "News and Events" tabs or by using the following link:  http://ir.edgewell.com/news-and-events/events

For those unable to participate during the live webcast, a re-play will be available on www.edgewell.com, under the "Investors," "Financial Reports," and "Quarterly Earnings" tabs. This release includes references to the Company's website and references to additional information and materials found on its website. The Company's website and such information and materials are not incorporated by reference in, and are not part of, this release.

About Edgewell

Edgewell is a leading pure-play consumer products company with an attractive, diversified portfolio of established brand names such as Schick®, Wilkinson Sword® and Billie® men's and women's shaving systems and disposable razors; Edge and Skintimate® shave preparations; Banana Boat®, Hawaiian Tropic®, Bulldog®,  Jack Black®, and CREMO® sun and skin care products; and Wet Ones® products. The Company has a broad global footprint and operates in more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,500 employees worldwide.

Forward-Looking Statements. This document contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on these statements. These forward-looking statements include, but are not limited to, statements concerning our expectations regarding our future results of operations and financial condition; including business trajectory and performance improvement; future growth and value creation; our capital allocation plans; future dividend payments; the effects of macroeconomic and geopolitical factors such as changes in tariffs, inflationary pressures, and conflicts or acts of war (such as the conflict in the Middle East). Additional forward-looking statements can generally be identified by the use of words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "will," "should," "forecast," "outlook," or other similar words or phrases. These statements are not based on historical facts, but instead reflect the Company's expectations, estimates or projections concerning future results or events, including, without limitation, the future earnings and performance of Edgewell or any of its businesses. Many factors outside our control could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause the Company's actual results to differ materially from those indicated by those statements. The Company cannot assure you that any of its expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document and the Company disclaims any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.

Factors that could cause fluctuations in our actual results include, but are not limited to, the following: our ability to compete in products and prices, as well as costs, in an intensely competitive industry; the loss of any of our principal customers or changes in the policies of our principal customers; our inability to design and execute a successful omnichannel strategy; our ability to attract, retain and develop key personnel; fluctuations in the price and supply of raw materials and costs of labor, warehousing and transportation; the impact of seasonal volatility on our sales, financial performance, working capital requirements and cash flow; the ability to successfully manage evolving global financial risks, including tariffs, foreign currency fluctuations, currency exchange or pricing controls and localized volatility; the ability to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, conflicts or acts of war (such as the conflict in the Middle East), terrorism or disease outbreaks; impacts from any loss of our principal customers or changes in the policies or strategies of our customers; our level of indebtedness and the various covenants related thereto, and to generate sufficient income and cash flow to allow the Company to effect expected share repurchases and dividend payments; our failure to maintain our brands' reputation and successfully respond to changing consumer habits; and perceptions of certain ingredients, negative perceptions of packaging, lack of recyclability or other environmental attributes; our access to capital markets and borrowing capacity; impairment of our goodwill and other intangible assets; the ability to successfully manage the financial, legal, reputational and operational risks associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; risks associated with our international operations; our ability to effectively integrate acquired companies and successfully manage divestiture activities; our ability to successfully implement our cost savings initiatives, including rationalization or restructuring efforts; the ability to rely on and maintain key Company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; the ability to effectively incorporate artificial intelligence ("AI") into our business; the ability to successfully achieve, maintain or adjust our environmental or sustainability goals and priorities; the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity and data protection, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; the ability to adequately protect our intellectual property rights; product quality and safety issues, including recalls and product liability;  losses or increased funding and expenses related to our pension plans; and the other important factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025 ("2025 Annual Report") under Part I. Item 1A. "Risk Factors," and in our other filings with the Securities and Exchange Commission ("SEC"). In addition, other risks and uncertainties not presently known to the Company or that it presently considers immaterial could significantly affect the accuracy of any such forward-looking statements. Risks and uncertainties include those detailed from time to time in the Company's publicly filed documents, including in Item 1A. Risk Factors of Part I of the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on November 18, 2025.

Non-GAAP Financial Measures. While the Company reports financial results in accordance with generally accepted accounting principles ("GAAP") in the U.S., this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as "adjusted" or "organic" and exclude items which are considered by the Company as unusual, non-recurring, or outside of ordinary operations and which may have a disproportionate positive or negative impact on the Company's financial results in any particular period. Reconciliations of non-GAAP measures, including reconciliations of measures related to the Company's fiscal 2027 financial outlook, are included within the Notes to Condensed Consolidated Financial Statements included with this release.

This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. The Company uses this non-GAAP information internally to make operating decisions and believes it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is a component in determining management's incentive compensation. Finally, the Company believes this information provides a higher degree of transparency. The following provides additional detail on the Company's non-GAAP measures:

• The Company utilizes "adjusted" non-GAAP measures including gross margin, SG&A, operating income, operating margin, effective tax rate, net earnings, earnings per share, EBITDA, and other (income) expense to internally make operating decisions.
  • Constant currency measures are calculated by removing the impact of translational and transactional foreign currencies changes, net of foreign currency hedges compared to the prior year. Transactional foreign currency changes are driven by foreign legal entities' transactions not denominated in local currency.
• The Company analyzes its net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency.
  • Segment profit is impacted by fluctuations in translation and transactional foreign currency. The impact of currency was applied to segments using management's best estimate.
• The Company presents certain metrics on a consolidated and continuing operations basis to help with comparability.
• Free cash flow is defined as net cash from operating activities, less capital expenditures plus collections of deferred purchase price of accounts receivable sold and proceeds from sales of fixed assets. Adjusted free cash flow is defined as free cash flow, adjusted for the following: the one-time operating cash flow impacts associated directly with Feminine Care divestiture including tax, working capital, and deal related fees and expenses.
• Net debt is defined as Gross debt less cash and cash equivalents. Net debt leverage ratio is defined as net debt divided by trailing twelve month adjusted EBITDA. Adjusted net debt leverage ratio is defined as net debt divided by continuing operations trailing twelve month adjusted EBITDA, which includes Transition Services Agreement income realized in fiscal 2026 Q2, Q3 and Q4 (eight months), plus $9 million of pro forma Transition Services Agreement income (four months). Refer to Supplemental Slides for fiscal year 2025 quarterly recast adjusted EBITDA reconciliation for continuing operations filed on February 9, 2026 at www.edgewell.com, under the "Investors," and "News and Events" tabs or by using the following link http://ir.edgewell.com/news-and-events/events for historical financial information related to the Company's divestiture of its Feminine Care business consistent with the continuing operations structure.

Basis of Presentation. In accordance with applicable accounting guidance, the results of the Feminine Care segment are presented as discontinued operations in the Condensed Consolidated Statements of Earnings and Comprehensive Income and, as such, have been excluded from both continuing operations and segment results for all periods presented. Further, the Company reclassified the assets and liabilities of the Feminine Care disposal group as assets and liabilities held for sale in the Condensed Consolidated Balance Sheet as of September 30, 2025. The Condensed Consolidated Statements of Cash Flows are presented on a consolidated basis with both continuing operations and discontinued operations. All amounts, percentages and disclosures for all periods presented reflect only the continuing operations of Edgewell unless otherwise noted.

The financial results included herein represent the most current information available to management and are preliminary until the Company's Annual Report on Form 10-K is filed with the SEC. Actual results may differ from these preliminary results and are subject to the completion of year-end accounting procedures and adjustments and the audit of the Company's consolidated financial statements. Please refer to the Form 10-K to be filed with the SEC on November 13, 2026.

EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (unaudited, in millions, except per share data)
	Three Months Ended September 30,				Twelve Months Ended September 30,
	2026		2025		2026		2025
Net sales	$               484.1		$               469.9		$            1,996.5		$            1,962.0
Cost of products sold	274.5		281.5		1,166.5		1,114.2
Gross profit	209.6		188.4		830.0		847.8
Selling, general and administrative expense	107.2		105.5		428.9		408.6
Advertising and sales promotion expense	56.1		45.9		243.5		227.9
Research and development expense	15.5		15.5		57.5		55.6
Restructuring charges	13.9		14.6		58.7		45.5
Operating income	16.9		6.9		41.4		110.2
Interest expense associated with debt	15.0		14.8		68.9		73.2
Other (income) expense, net	(8.3)		2.1		(26.7)		(0.2)
(Loss) earnings from continuing operations before income taxes	10.2		(10.0)		(0.8)		37.2
Income tax provision (benefit) on continuing operations	(0.5)		(22.1)		1.4		(7.1)
Net (loss) earnings from continuing operations	10.7		12.1		(2.2)		44.3
(Loss) earnings from discontinued operations, net of tax	0.2		(42.7)		(49.5)		(18.9)
Net (loss) earnings	$                 10.9		$                (30.6)		$                (51.7)		$                 25.4
Basic (loss) earnings per share
Continuing operations	$                 0.23		$                 0.26		$                (0.05)		$                 0.93
Discontinued operations	—		(0.92)		(1.07)		(0.40)
Basic (loss) earnings per share	$                 0.23		$                (0.66)		$                (1.12)		$                 0.53
Diluted (loss) earnings per share
Continuing operations	$                 0.23		$                 0.26		$                (0.05)		$                 0.93
Discontinued operations	—		(0.92)		(1.07)		(0.40)
Diluted (loss) earnings per share	$                 0.23		$                (0.66)		$                (1.12)		$                 0.53
Weighted-average shares outstanding:
Basic	46.1		46.5		46.3		47.5
Diluted	47.2		46.5		46.3		47.6
See Accompanying Notes.

 

EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in millions)
	September 30, 2026		September 30, 2025
Assets
Current assets
Cash and cash equivalents	$               375.6		$               225.7
Trade receivables, less allowance for doubtful accounts	132.4		137.8
Inventories	445.4		433.8
Other current assets	166.4		138.6
Current assets held for sale	—		59.6
Total current assets	1,119.8		995.5
Property, plant and equipment, net	296.7		295.0
Goodwill	1,133.1		1,137.1
Other intangible assets, net	799.5		828.2
Other assets	199.4		178.7
Non-current assets held for sale	—		321.8
Total assets	$            3,548.5		$            3,756.3
Liabilities and Shareholders' Equity
Current liabilities
Notes payable	$                 38.8		$                 29.5
Accounts payable	209.7		219.7
Other current liabilities	367.5		311.1
Current liabilities held for sale	—		5.2
Total current liabilities	616.0		565.5
Long-term debt	1,245.5		1,383.3
Deferred income tax liabilities	79.2		118.8
Other liabilities	135.8		135.6
Total liabilities	2,076.5		2,203.2
Shareholders' equity
Common shares	0.7		0.7
Additional paid-in capital	1,573.4		1,578.8
Retained earnings	1,005.8		1,086.7
Common shares in treasury at cost	(997.1)		(1,003.3)
Accumulated other comprehensive loss	(110.8)		(109.8)
Total shareholders' equity	1,472.0		1,553.1
Total liabilities and shareholders' equity	$            3,548.5		$            3,756.3
See Accompanying Notes.

 

EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, in millions)
	Twelve Months Ended September 30,
	2026		2025
Cash Flow from Operating Activities
Net (loss) earnings	$                    (51.7)		$                      25.4
Depreciation and amortization	77.8		88.8
Share-based compensation expense	19.0		24.5
Loss on sale of assets	1.3		1.9
Impairment charges	37.4		51.1
Loss on assets held for sale	2.2		—
Deferred compensation payments	(2.3)		(3.1)
Deferred income taxes	(43.9)		(21.7)
Other, net	(2.0)		(22.7)
Changes in operating assets and liabilities	11.8		(25.8)
Net cash provided by operating activities	49.6		118.4
Cash Flow from Investing Activities
Proceeds from sale of business	338.9		—
Capital expenditures	(59.6)		(77.0)
Collection of deferred purchase price on accounts receivable sold	4.0		5.6
Other, net	5.9		(1.5)
Net cash provided by (used in) investing activities	289.2		(72.9)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	398.0		931.0
Cash payments on debt with original maturities greater than 90 days	(538.0)		(825.0)
Net proceeds from debt with original maturities of 90 days or less	7.3		5.5
Repurchase of shares	(15.8)		(90.2)
Dividends to common shareholders	(28.4)		(29.3)
Employee shares withheld for taxes	(2.9)		(7.5)
Net financing (outflow) inflow from the Accounts Receivable Facility	(2.6)		(14.1)
Other, net	(0.4)		(0.4)
Net cash used in financing activities	(182.8)		(30.0)
Effect of exchange rate changes on cash	(6.1)		1.1
Net increase (decrease) in cash and cash equivalents	149.9		16.6
Cash and cash equivalents, beginning of period	225.7		209.1
Cash and cash equivalents, end of period	$                    375.6		$                    225.7
See Accompanying Notes.

EDGEWELL PERSONAL CARE COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, in millions, except per share data)

Note 1 —  Segments

The Company conducts its business in the following two segments: Wet Shave and Sun and Skin Care (collectively, the "Segments," and each individually, a "Segment"). Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, items which are considered by the Company to be unusual or non-recurring and which may have a disproportionate positive or negative impact on the Company's financial results in any particular period and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.

Segment net sales and profitability are presented below:

	Three Months Ended September 30,				Twelve Months Ended September 30,
	2026		2025		2026		2025
Net sales
Wet Shave	$             325.8		$             321.9		$       1,224.0		$          1,218.9
Sun and Skin Care	158.3		148.0		772.5		743.1
Total net sales	$             484.1		$             469.9		$       1,996.5		$          1,962.0
Segment Profit
Wet Shave	$               58.7		$               53.0		$          164.7		$             190.3
Sun and Skin Care	19.7		5.0		109.2		98.4
Total segment profit	78.4		58.0		273.9		$             288.7
General corporate and other expenses	(20.9)		(24.0)		(87.1)		(89.8)
Amortization of intangibles	(6.3)		(6.4)		(25.3)		(25.6)
Interest and other expense, net	(6.4)		(17.6)		(43.9)		(76.2)
Restructuring and related costs	(29.9)		(18.0)		(101.8)		(50.7)
Acquisition and integration costs	—		—		—		(0.5)
Sun Care reformulation costs	(1.0)		(1.3)		(4.4)		(3.5)
Legal matters	(1.8)		—		(7.5)		—
(Loss) gain on investment	(0.4)		—		1.1		0.9
Commercial realignment	—		0.1		0.2		(2.9)
Other project and related costs	(1.5)		(0.8)		(6.0)		(3.2)
Total earnings (loss) before income taxes	$               10.2		$             (10.0)		$             (0.8)		$               37.2

Refer to Note 2 - GAAP to Non-GAAP Reconciliations below for the income statement location of non-GAAP adjustments to earnings before income taxes.

Note 2 — GAAP to Non-GAAP Reconciliations

The following tables provide a GAAP to Non-GAAP reconciliation of certain line items from the Condensed Consolidated Statement of Earnings:

Three Months Ended September 30, 2026
	Gross Profit		SG&A		Operating Income		EBIT (Loss) from Continuing Operations (1)		Income Tax Provision (Benefit) from Continuing Operations		Net (Loss) Income from Continuing Operations		Diluted EPS from Continuing Operations
GAAP — Reported	$       209.6		$       107.2		$         16.9		$           10.2		$            (0.5)		$           10.7		$         0.23
Restructuring and related costs	11.5		(4.5)		29.9		29.9		7.4		22.5		0.48
Sun Care reformulation costs	—		—		1.0		1.0		0.3		0.7		0.01
Legal matters	—		(1.8)		1.8		1.8		0.3		1.5		0.03
Loss on investment	—		—		—		0.4		0.1		0.3		0.01
Other project and related costs	—		(1.3)		1.5		1.5		0.4		1.1		0.02
Total Adjusted Non-GAAP	$       221.1		$         99.6		$         51.1		$           44.8		$             8.0		$           36.8		$         0.78
							Adjusted Non-GAAP Constant Currency						0.67
GAAP as a percent of net sales	43.3 %		22.1 %		3.5 %		GAAP effective tax rate						(5.2) %
Adjusted as a percent of net sales	45.7 %		20.6 %		10.6 %		Adjusted effective tax rate						17.9 %
Adjusted Constant Currency as a percent of net sales	44.8 %				9.7 %

(1) EBIT is defined as Earnings (Loss) before Income taxes.

 

Three Months Ended September 30, 2025
	Gross Profit		SG&A		Operating Income		EBIT (Loss) from Continuing Operations (1)		Income Tax Provision (Benefit) from Continuing Operations		Net (Loss) Income from Continuing Operations		Diluted EPS from Continuing Operations
GAAP — Reported	$      188.4		$      105.5		$          6.9		$          (10.0)		$          (22.1)		$           12.1		$        0.26
Restructuring and related costs	2.3		(1.1)		18.0		18.0		4.5		13.5		0.29
Sun Care reformulation costs	—		—		1.3		1.3		0.3		1.0		0.02
Commercial realignment	(0.1)		—		(0.1)		(0.1)		—		(0.1)		—
Other project and related costs	—		(1.6)		1.6		0.8		0.2		0.6		0.01
Germany re-rate	—		—		—		—		2.8		(2.8)		(0.06)
Total Adjusted Non-GAAP	$      190.6		$      102.8		$        27.7		$           10.0		$          (14.3)		$           24.3		$        0.52
GAAP as a percent of net sales	40.1 %		22.5 %		1.5 %		GAAP effective tax rate						221.0 %
Adjusted as a percent of net sales	40.6 %		21.9 %		5.9 %		Adjusted effective tax rate						(142.8) %

(1) EBIT is defined as Earnings (Loss) before Income taxes.

 

Twelve Months Ended September 30, 2026
	Gross Profit		SG&A		Operating Income		EBIT (Loss) from Continuing Operations (1)		Income Tax Provision (Benefit) from Continuing Operations		Net (Loss)  Income from Continuing Operations		Diluted EPS from Continuing Operations
GAAP — Reported	$       830.0		$       428.9		$         41.4		$            (0.8)		$             1.4		$            (2.2)		$       (0.05)
Restructuring and related costs	37.2		(5.9)		101.8		101.8		25.1		76.7		1.64
Sun Care reformulation costs	—		—		4.4		4.4		1.1		3.3		0.07
Legal matters	—		(7.5)		7.5		7.5		1.7		5.8		0.12
Gain on investment	—		—		—		(1.1)		(0.2)		(0.9)		(0.02)
Commercial realignment	(0.2)		—		(0.2)		(0.2)		(0.1)		(0.1)		—
Other project and related costs	0.1		(6.4)		6.7		6.0		1.5		4.5		0.10
Tax shortfall on equity compensation	—		—		—		—		(3.4)		3.4		0.07
Total Adjusted Non-GAAP	$       867.1		$       409.1		$       161.6		$          117.6		$           27.1		$           90.5		$         1.93
							Adjusted Non-GAAP Constant Currency						1.73
GAAP as a percent of net sales	41.6 %		21.5 %		2.1 %		GAAP effective tax rate						(175.3) %
Adjusted as a percent of net sales	43.4 %		20.5 %		8.1 %		Adjusted effective tax rate						23.0 %
Adjusted Constant Currency as a percent of net sales	43.0 %				7.6 %

(1) EBIT is defined as Earnings (Loss) before Income taxes.

 

Twelve Months Ended September 30, 2025
	Gross Profit		SG&A		Operating Income		EBIT (Loss) from Continuing Operations (1)		Income Tax Provision (Benefit) from Continuing Operations		Net (Loss) Income from Continuing Operations		Diluted EPS from Continuing Operations
GAAP — Reported	$      847.8		$      408.6		$      110.2		$          37.2		$           (7.1)		$          44.3		$        0.93
Restructuring and related costs	3.5		(1.7)		50.7		50.7		12.5		38.2		0.80
Acquisition and integration costs	—		(0.5)		0.5		0.5		0.1		0.4		0.01
Sun Care reformulation costs	—		—		3.5		3.5		0.8		2.7		0.06
Gain on investment	—		—		—		(0.9)		—		(0.9)		(0.02)
Commercial realignment	2.9		—		2.9		2.9		0.9		2.0		0.04
Other project and related costs	—		(5.5)		5.5		3.2		0.8		2.4		0.05
Germany re-rate	—		—		—		—		2.8		(2.8)		(0.06)
Total Adjusted Non-GAAP	$      854.2		$      400.9		$      173.3		$          97.1		$          10.8		$          86.3		$        1.81
GAAP as a percent of net sales	43.2 %		20.8 %		5.6 %		GAAP effective tax rate						(19.1) %
Adjusted as a percent of net sales	43.5 %		20.4 %		8.8 %		Adjusted effective tax rate						11.0 %

(1) EBIT is defined as Earnings (Loss) before Income taxes.

Note 3 - Net Sales and Profit (Loss) by Segment

Operations for the Company are reported via two segments. The following tables present changes in net sales and segment profit for the three and twelve months ended September 30, 2026, as compared to the corresponding periods in the prior year.

Net Sales
Quarter Ended September 30, 2026	Wet Shave				Sun and Skin Care				Total
Net sales -  Q4 2025	$           321.9				$           148.0				$           469.9
Organic	5.2		1.6 %		9.5		6.5 %		14.7		3.1 %
Impact of currency	(1.3)		(0.4) %		0.8		0.5 %		(0.5)		(0.1) %
Net sales -  Q4 2026	$           325.8		1.2 %		$           158.3		7.0 %		$           484.1		3.0 %
Segment Profit
Quarter Ended September 30, 2026	Wet Shave				Sun and Skin Care				Total
Segment profit -  Q4 2025	$             53.0				$               5.0				$             58.0
Organic	2.5		4.8 %		13.9		278.0 %		16.4		28.3 %
Impact of currency	3.2		6.0 %		0.8		16.0 %		4.0		6.9 %
Segment profit -  Q4 2026	$             58.7		10.8 %		$             19.7		294.0 %		$             78.4		35.2 %
Net Sales
Twelve Months Ended September 30, 2026	Wet Shave				Sun and Skin Care				Total
Net sales - fiscal 2025	$        1,218.9				$           743.1				$        1,962.0
Organic	(14.6)		(1.2) %		20.9		2.8 %		6.3		0.3 %
Impact of currency	19.7		1.6 %		8.5		1.2 %		28.2		1.5 %
Net sales - fiscal 2026	$        1,224.0		0.4 %		$           772.5		4.0 %		$        1,996.5		1.8 %
Segment Profit
Twelve Months Ended September 30, 2026	Wet Shave				Sun and Skin Care				Total
Segment profit -  fiscal 2025	$           190.3				$             98.4				$           288.7
Organic	(33.9)		(17.9) %		7.6		7.7 %		(26.3)		(9.1) %
Impact of currency	8.3		4.4 %		3.2		3.3 %		11.5		4.0 %
Segment profit -  fiscal 2026	$           164.7		(13.5) %		$           109.2		11.0 %		$           273.9		(5.1) %

For all tables, the impact of currency to segment profit includes both the translational and transactional currency changes during the quarter and fiscal year.

Note 4 - Net Debt and EBITDA

The Company reports financial results on a GAAP and adjusted basis. The tables below are used to reconcile Net Debt and Net earnings to EBITDA and Adjusted EBITDA, which are non-GAAP measures, to improve comparability of results between periods.

	September 30, 2026		September 30, 2025
Notes payable	$                 38.8		$                 29.5
Long-term debt	1,245.5		1,383.3
Gross debt	1,284.3		1,412.8
Less: Cash and cash equivalents	375.6		225.7
Net debt	$               908.7		$            1,187.1

 

	Three Months Ended September 30,				Twelve Months Ended September 30,
	2026		2025		2026		2025
Net earnings (loss)	$                  10.7		$                  12.1		$                  (2.2)		$                  44.3
Income tax provision	(0.5)		(22.1)		1.4		(7.1)
Interest expense, net	13.6		14.2		64.3		71.1
Depreciation and amortization	18.8		19.4		76.5		73.3
EBITDA	42.6		23.6		140.0		181.6
Restructuring and related costs (1)	29.5		17.4		97.9		48.9
Acquisition and integration costs	—		—		—		0.5
Sun Care reformulation costs	1.0		1.3		4.4		3.5
Legal matters	1.8		—		7.5		—
(Gain) loss on investment	0.4		—		(1.1)		(0.9)
Commercial realignment	—		(0.1)		(0.2)		2.9
Other project and related costs	1.5		0.8		6.0		3.2
Adjusted EBITDA	$                  76.8		$                 43.0		$                254.5		$                239.7

(1) Excludes $0.4 million and $3.9 million of accelerated depreciation, which is included within Depreciation and amortization during the three and twelve months ended September 30,  2026, respectively and $0.6 million and $1.8 million during the three and twelve months ended September 30, 2025, respectively.

Note 5 - Outlook for Continuing Operations

The following tables provide reconciliations of Adjusted EPS and Adjusted EBITDA, Non-GAAP measures, included within the Company's projected fiscal 2027 outlook for continuing operations. The below outlook reflects management's approximate expectations and is subject to rounding adjustments. As a result, the sum of individual amounts may not precisely equal the totals presented.

Adjusted EPS Outlook
Fiscal 2027 GAAP EPS	approx.	$0.90 - $1.20
Restructuring and related costs	approx.	1.17
Sun Care reformulation costs	approx.	0.09
Other costs	approx.	0.02
Income taxes(1)	approx.	(0.33)
Fiscal 2027 Adjusted EPS Outlook (Non-GAAP)	approx.	$1.85 - $2.15

(1)  Income tax effect of the adjustments to Fiscal 2027 GAAP EPS noted above.

 

Adjusted EBITDA Outlook
Fiscal 2027 GAAP Net Income	approx.	$42 - $57
Income tax provision	approx.	$11 - $16
Interest expense, net of $3 interest income	approx.	64
Depreciation and amortization	approx.	73
EBITDA	approx.	$190 - $210
Restructuring and related costs	approx.	55
Sun Care reformulation costs	approx.	4
Other costs	approx.	1
Fiscal 2027 Adjusted EBITDA	approx.	$250 - $270

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-fourth-quarter-and-fiscal-2026-results-302937646.html

SOURCE Edgewell Personal Care Company

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Edgewell's fourth-quarter fiscal 2026 sales and earnings?

Edgewell reported sales of $484.1 million, up 3.0%, and continuing-operations diluted earnings per share of $0.23, down from $0.26. Organic sales increased 3.1%. Adjusted earnings per share increased to $0.78 from $0.52 in the prior-year quarter.

What is Edgewell's fiscal 2027 financial outlook?

Edgewell expects organic sales growth of approximately 1.0%–3.0%, GAAP earnings per share of $0.90–$1.20 and adjusted earnings per share of $1.85–$2.15. Adjusted EBITDA is expected at $250–$270 million, and adjusted free cash flow is expected at approximately $100–$120 million.

When will Edgewell pay its declared $0.15 quarterly dividend?

Edgewell's $0.15 per common share quarterly dividend is payable on January 7, 2027, to shareholders of record at the close of business on December 3, 2026. The board declared the dividend on November 12, 2026. Edgewell paid $6.9 million in dividends during its fourth fiscal quarter.

What drove Edgewell's fiscal 2026 restructuring costs?

Edgewell's $101.8 million in pre-tax restructuring and related costs included $80.0 million for consolidating Mexico facilities and Wet Shave operations and $21.8 million for global transformation actions. The costs consisted largely of severance, project implementation and other exit costs.

Why did Edgewell's operating cash flow decline in fiscal 2026?

The decline largely reflected one-time operating cash flow impacts directly associated with the Feminine Care divestiture, including taxes, working capital, and deal-related fees and expenses. Consolidated operating cash flow, including continuing and discontinued operations, was $49.6 million versus $118.4 million in the prior year.